Lifeline Biotechnologies, Inc. (LLBO)
OTCMKTS · Delayed Price · Currency is USD
0.0007
0.00 (0.00%)
At close: Jan 22, 2026
Lifeline Biotechnologies Market Cap
Lifeline Biotechnologies has a market cap or net worth of $3.04 million as of January 23, 2026. Its market cap has increased by 75.00% in one year.
Market Cap
3.04M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 31, 2003, Lifeline Biotechnologies's market cap has decreased from 18.97M to 3.04M, a decrease of -83.95%. That is a compound annual growth rate of -7.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 3.04M | - |
| Dec 31, 2025 | 3.04M | 600.00% |
| Dec 31, 2024 | 434.89K | -35.07% |
| Dec 28, 2023 | 669.78K | -33.33% |
| Dec 30, 2022 | 1.00M | 50.00% |
| Dec 31, 2021 | 669.78K | -60.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADM Tronics Unlimited | 7.30M |
| Kelyniam Global | 6.97M |
| REMSleep Holdings | 6.88M |
| Odyssey Health | 6.27M |
| Co-Diagnostics | 6.07M |
| IR-Med | 3.86M |
| Vycor Medical | 3.67M |
| Fuse Medical | 3.40M |